S&P 500
5,975.47
+0.1%
+$5.10
DJI
42,540.53
+0.0%
+$20.89
NASDAQ
19,426.65
+0.1%
+$27.69
Bitcoin
105,285.00
-1.1%
-1,171.22
AAPL
$202.87
-0.2%
-$0.40
AMZN
$206.63
+0.4%
+$0.92
GOOG
$168.16
+0.3%
+$0.45
META
$681.81
+2.2%
+$14.96
MSFT
$464.14
+0.3%
+$1.17
NVDA
$140.66
-0.4%
-$0.56
TSLA
$332.74
-3.3%
-$11.53
Q32 Bio (NASDAQ: QTTB)
$1.92
(0.3%)
$0.00
Price as of June 4, 2025, 12:30 p.m. ET
Q32 Bio Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Q32 Bio Company Info
Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.